ChroMedX Reports Testing of Key HemoPalm Analyzer Component
ChroMedX Corp. (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to report that testing has commenced on the key spectroscopic component of the Analyzer of HemoPalm(TM) blood analysis device.
View full press release